Array BioPharma Inc., of Boulder, Colo., appointed Michael N. Needle chief medical officer...Vermillion Inc., of Austin, Texas, appointed Thomas McLain president and CEO

Protea Biosciences Inc., of Morgantown, W. Va., added Thijs Spoor and Josiah T. Austin to its board...Sutro Biopharma Inc., of San Francisco, appointed Edward C. Albini chief financial officer

Array BioPharma Inc., of Boulder, Colo., added John Orwin to its board...HemoShear LLC, of Charlottesville, Va., added Mehmood Khan and Frederick W.K. Brown to its board

Sutro Biopharma Inc., of San Francisco, appointed Jeremy Bender chief business officer and Aaron K. Sato vice president, research

Galena Biopharma Inc., of Lake Oswego, Ore., appointed Gabriel Hortobagyi to its scientific advisory board...Macrocure, of Petach Tikva, Israel, named Nissim Mashiach president and CEO

Galena Biopharma Inc., of Lake Oswego, Ore., named Rosemary Mazanet executive vice president and chief medical officer and appointed Robert Figlin to its scientific advisory board

PDL BioPharma Inc., of Incline Village, Nev., appointed Bruce Tomlinson vice president and chief financial officer, effective June 11

Array BioPharma Inc., of Boulder, Colo., appointed Howard Holden vice president of regulatory affairs and quality assurance

Genesis Biopharma Inc., of Los Angeles, named Hans Bishop executive chairman of its board...Silence Therapeutics plc, of London, appointed Detlef Schuppan and Massimo Pinzani to its newly created scientific advisory board

Sutro Biopharma Inc., of San Francisco, appointed James A. Wells and James R. Swartz to its scientific advisory board

Genesis Biopharma Inc., of Los Angeles, named Steven A. Rosenberg to its scientific and medical advisory board...Groove Biopharma Inc., of Seattle, promoted David L. McElligott to chief scientific officer

AVI BioPharma Inc., of Bothell, Wash., appointed Jayant Aphale senior vice president of technical operations...BioTime Inc., of Alameda, Calif., and its subsidiary, OncoCyte Corp., each appointed Andrew von Eschenbach to their boards

PDL BioPharma Inc., of Incline Village, Nev., retained Franklin M. Berger and Evan Bedil as advisors to assist with the identification and evaluation of royalty-bearing asset acquisition opportunities

Galena Biopharma Inc., of Lake Oswego, Ore., named Hana B. Moran vice president of regulatory affairs and compliance

Genesis Biopharma Inc., of Los Angeles, added David Voyticky and Merrill A. McPeak to its board and named Laszlo Radvanyi to its scientific and medical advisory board

Genesis Biopharma Inc., of Los Angeles, added Gray Davis as chairman of its corporate advisory board...It also named Patrick Hwu and Mario Sznol to its recently formed scientific and medical advisory board and named Martin Schroeder to its board

AVI BioPharma Inc., of Bothell, Wash., appointed Ed Kaye chief medical officer, effective June 20...Cytochroma Inc., of Markham, Ontario, appointed Cynthia Lavoie and Osamu Otani to its board

Actelion Ltd., of Allschwil, Switzerland, nominated Jean-Pierre Garnier and Robert Bertolini to its board...AVI BioPharma Inc., of Bothell, Wash., appointed Peter S. Linsley chief scientific officer, effective May 1

Genesis Biopharma Inc., of Los Angeles, appointed William H. Andrews to its board...Hospira Inc., of Lake Forest, Ill., elected F. Michael (Mike) Ball CEO and board member